Nucleus

Nucleus

Early Stage

a venture studio for psychedelics

a venture studio for psychedelics

Overview

Raised to Date: Raised: $521,349

Total Commitments ($USD)

Platform

Wefunder

Start Date

10/20/2022

Close Date

04/29/2023

Min. Goal
$500,000
Max. Goal
$3,000,000
Min. Investment

$200

Security Type

SAFE

Series

Pre-Seed

SEC Filing Type

RegCF    Open SEC Filing

Early Bird Val. Cap

$10,000,000

Valuation Cap

$12,000,000

Discount

15%

Rolling Commitments ($USD)

Status
Funded
Reporting Date

04/30/2023

Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise

$2,730

# of Investors

136

Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2021

Industry

Business Services, Software, & Applications

Tech Sector

EnterpriseTech

Distribution Model

B2B/B2C

Margin

Medium

Capital Intensity

Low

Location

Fort Lauderdale, Florida

Business Type

Growth

Nucleus, with a valuation of $12 million, is raising funds on Wefunder. It is a venture studio for psychedelics that builds brands to educate the masses, activate new stakeholders, and distribute data about powerful medicines. Nucleus’ platform, Neuly, connects people with the psychedelics industry and works for investors, potential patients, practitioners, and professionals within the industry. Nucleus has 50,000 subscribers, a growing network of 3,000 care practitioners, and a sales pipeline of 200 psychedelic companies. Logan Lenz, Dustin Robinson, and Robert Velarde founded Nucleus in June 2021. The current crowdfunding campaign has a minimum target of $500,000 and a maximum target of $3 million. The campaign proceeds will be used for scaling and improving the platform, content development and marketing, industry data and research, and operational improvements.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-141,038

$0

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$20,813

$0

Accounts Receivable

$0

$0

Total Assets

$770,813

$0

Short-Term Debt

$24,980

$0

Long-Term Debt

$81,000

$0

Total Liabilities

$105,980

$0

Financials as of: 10/20/2022
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.

Create your first portfolio

Create your own startup investment portfolio on KingsCrowd.

Track all of your startup investments in one place using our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Nucleus on Wefunder 2022
Platform: Wefunder
Security Type: SAFE
Valuation: $12,000,000

Follow company

Follow Nucleus on Wefunder 2022

Buy Nucleus's Deal Report

Warning: according to the close date for this deal, Nucleus may no longer be accepting investments.

Nucleus Deal Report

Get KingsCrowd’s comprehensive report on Nucleus including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Nucleus is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Nucleus deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge